-David J Baylink Researcher Activity Profile

Research Author Detailed Information 

David J Baylink Publication Rate By Year

David J Baylink has published 1 paper(s) in 1978, 2 paper(s) in 1982, 1 paper(s) in 1984, 2 paper(s) in 1986, 1 paper(s) in 1987, 2 paper(s) in 1988, 3 paper(s) in 1989, 1 paper(s) in 1990, 1 paper(s) in 1997, 1 paper(s) in 2002, 1 paper(s) in 2003, 5 paper(s) in 2006, 11 paper(s) in 2007, 1 paper(s) in 2008, for a total of 33 research publications in total.

David J Dj Baylink Author Information

LAST NAME: baylink

FIRST NAME: David J

INITIALS: dj

AFFILIATION:

Papers

David J Baylink's Publication Record

1. Identification of mouse Duffy antigen receptor for chemokines (Darc) as a BMD QTL gene. Year Published: 2007
Musculoskeletal Disease Center, Jerry L. Pettis Memorial VA Medical Center, and Department of Medicine and Biochemistry, Loma Linda University, California 92357, USA.
2. ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Year Published: 2002
Musculoskeletal Diseases Center, Jerry L. Pettis VA Medical Center, 11201 Benton Street, Loma Linda, California 92357, USA. mohans@lom.med.va.gov
3. Osteogenic protein-1 stimulates mRNA levels of BMP-6 and decreases mRNA levels of BMP-2 and -4 in human osteosarcoma cells. Year Published: 1997
Department of Medicine, Loma Linda University, California, USA.
4. New quantitative trait loci that regulate wound healing in an intercross progeny from DBA/1J and 129 x 1/SvJ inbred strains of mice. Year Published: 2006
Musculoskeletal Disease Center, Jerry L. Pettis Memorial Veterans Administration Medical Center, Loma Linda, CA 92357, USA.
5. Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice. Year Published: 2006
Musculoskeletal Disease Center, 151, Jerry L. Pettis Memorial Veterans Affairs Medical Center, 11201 Benton Street, Loma Linda, CA 92357, USA.
6. Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo. Year Published: 2006
Musculoskeletal Disease Center, J. L. Pettis Veterans Affairs Medical Center (151), 11201 Benton Street, and Department of Medicine, Loma Linda University, California 92357, USA. Xuezhong.Qin@med.va.gov
7. Mapping genetic loci that regulate lipid levels in a NZB/B1NJxRF/J intercross and a combined intercross involving NZB/B1NJ, RF/J, MRL/MpJ, and SJL/J mouse strains. Year Published: 2007
Musculoskeletal Disease Center, Loma Linda VA Health Care Systems, Loma Linda, CA, USA.
8. Nuclear factor-E2-related factor-1 mediates ascorbic acid induction of osterix expression via interaction with antioxidant-responsive element in bone cells. Year Published: 2007
Musculoskeletal Disease Center, Jerry L Pettis Memorial Veterans Affairs Medical Center, Loma Linda, CA 92357, USA.
9. Genetic regulation of femoral bone mineral density: complexity of sex effect in chromosome 1 revealed by congenic sublines of mice. Year Published: 2007
Musculoskeletal Disease Center, Jerry L. Pettis Memorial VA Medical Center, 11201 Benton Street, and Department of Biochemistry, Loma Linda University, CA 92357, USA.
10. Disruption of insulin-like growth factor-I expression in type IIalphaI collagen-expressing cells reduces bone length and width in mice. Year Published: 2007
Jerry L. Pettis Veterans Affairs Medical Center and Loma Linda University, Loma Linda, California 92357, USA.
11. Sca-1(+) hematopoietic cell-based gene therapy with a modified FGF-2 increased endosteal/trabecular bone formation in mice. Year Published: 2007
Musculoskeletal Disease Center, Jerry L. Pettis Memorial V.A. Medical Center, Loma Linda, California 92357, USA.
12. Conditional Deletion of Insulin-Like Growth Factor-I in Collagen Type 1{alpha}2-Expressing Cells Results in Postnatal Lethality and a Dramatic Reduction in Bone Accretion. Year Published: 2007
Musculoskeletal Disease Center (151), Jerry L. Pettis Memorial Veterans Affairs Medical Center, 11201 Benton Street, Loma Linda, California 92357. subburaman.mohan@va.gov.
13. Mouse chromosome 9 quantitative trait loci for soft tissue regeneration: Congenic analysis and fine mapping. Year Published: 2007
Musculoskeletal Disease Center, Jerry L. Pettis Memorial VA Medical Center, Loma Linda, California, USA.
14. Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion. Year Published: 2007
Musculoskeletal Disease Center, Jerry L. Pettis Memorial Veterans Affairs Medical Center, 11201 Benton Street, Loma Linda, CA 92357, USA.
15. A missense mutation in the mouse Col2a1 gene causes spondyloepiphyseal dysplasia congenita, hearing loss, and retinoschisis. Year Published: 2003
The Jackson Laboratory, Bar Harbor, Maine 04609, USA. lrd@jax.org
16. Sca-1(+) hematopoietic cell-based gene therapy with a modified FGF-2 increased endosteal/trabecular bone formation in mice. Year Published: 2007
Musculoskeletal Disease Center, Jerry L. Pettis Memorial V.A. Medical Center, Loma Linda, California 92357, USA.
17. Regulation of insulin-like growth factor binding protein-5, four and a half lim-2, and a disintegrin and metalloprotease-9 expression in osteoblasts. Year Published: 2006
Musculoskeletal Disease Center (151), Jerry L. Pettis Memorial Veterans Affairs Medical Center, 11201 Benton Street, Loma Linda, CA 92357, USA.
18. Whole genome microarray analysis of growth hormone-induced gene expression in bone: T-box3, a novel transcription factor, regulates osteoblast proliferation. Year Published: 2006
Musculoskeletal Disease Center (151 Jerry L. Pettis Memorial Veterans Affairs Medical Center, 11201 Benton St., Loma Linda, CA 92357, USA.
19. Mouse chromosome 9 quantitative trait loci for soft tissue regeneration: congenic analysis and fine mapping. Year Published: 2007
Musculoskeletal Disease Center, Jerry L. Pettis Memorial VA Medical Center, Loma Linda, California 92357, USA.
20. A chemical mutagenesis screen to identify modifier genes that interact with growth hormone and TGF-beta signaling pathways. Year Published: 2008
Musculoskeletal Disease Center, Loma Linda VA Health Care Systems, Loma Linda, CA 92357, USA; Department of Medicine, Loma Linda University, Loma Linda, CA 92354, USA.
21. Purification of a skeletal growth factor from human bone. Year Published: 1982
22. Human skeletal growth factor: characterization of the mitogenic effect on bone cells in vitro. Year Published: 1982
23. Characterization of cells isolated and cultured from human bone. Year Published: 1984
24. Human skeletal growth factor stimulates collagen synthesis and inhibits proliferation in a clonal osteoblast cell line (MC3T3-E1). Year Published: 1986
25. Isolation and purification of a low-molecular-weight skeletal growth factor from human bones. Year Published: 1986
26. Skeletal growth factor is produced by human osteoblast-like cells in culture. Year Published: 1987
27. Purification of bovine skeletal growth factor. Year Published: 1988
28. Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Year Published: 1988
Department of Biochemistry, Loma Linda University, CA.
29. Vanadate stimulates bone cell proliferation and bone collagen synthesis in vitro. Year Published: 1989
Department of Medicine, Loma Linda University, California.
30. Effect of bone matrix-derived growth factors on skull and tibia in the growing rat. Year Published: 1989
Mineral Metabolism Unit, Veterans Administration Hospital, Loma Linda, California.
31. Bovine skeletal growth factor stimulates protein phosphorylation of chicken bone cells in vitro. Year Published: 1989
Department of Medicine, Loma Linda University, CA 92357.
32. Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells. Year Published: 1990
Department of Medicine, Loma Linda University, CA.
33. Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy. Year Published: 1978